KPIs & Operating Metrics(New)
Accured ExpensesAdjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By SegmentAdjusted Ebitda Margin By Segment AnnualBetterhelp Revenue BreakdownBetterhelp Revenue Breakdown AnnualBreakdown Of AssetsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross Profit %Income Before Income TaxesLong Lived Assets By GeographyNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOperating StatisticsOperating Statistics AnnualOpex As A % Of RevenueProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment, NetRemaining Performance ObligationRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By TypeRevenue By Type %Revenue By Type AnnualRevenue By Type Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Cost Of Revenue (2022 - 2025)

Teladoc Health's Cost of Revenue history spans 12 years, with the latest figure at -$91.3 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 115.24% year-over-year to -$91.3 million; the TTM value through Dec 2025 reached $194.5 million, down 81.0%, while the annual FY2025 figure was $194.5 million, 74.11% down from the prior year.
  • Cost of Revenue for Q4 2025 was -$91.3 million at Teladoc Health, down from $187.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $599.0 million in Q4 2024 and bottomed at -$352.8 million in Q4 2023.
  • The 5-year median for Cost of Revenue is $181.1 million (2022), against an average of $95.5 million.
  • The largest YoY upside for Cost of Revenue was 1192.02% in 2021 against a maximum downside of 339.18% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at -$224.7 million in 2021, then crashed by 45.95% to -$327.9 million in 2022, then fell by 7.59% to -$352.8 million in 2023, then surged by 269.77% to $599.0 million in 2024, then crashed by 115.24% to -$91.3 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Cost of Revenue are -$91.3 million (Q4 2025), $187.2 million (Q3 2025), and -$98.2 million (Q2 2025).